cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.3886/e115282v1-95860
title: Data and Code for: "Why Special Economic Zones? Using Trade Policy to Discriminate Across Importers"

description: Tariffs are generally assumed to depend on the product, not the identity of the importer. However, special economic zones are a common, economically important policy used worldwide to lower tariffs on selected goods for selected manufacturers. I show this is motivated by policymakers' desire to discriminate across buyers when a tax is intended to raise prices for sellers, through a mechanism distinct from existing theories of optimal taxation. Using a new dataset compiled from public records and exogenous changes in imports of intermediate goods, I find the form, composition, and size of U.S. zones are consistent with the theory.<br><br>
DOI: 10.5519/qd.95o9i2b7
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (1 records)
DOI: 10.5281/zenodo.851635
title: Multihole water oxidation catalysis on hematite photoanodes revealed by operando spectroelectrochemistry and density functional theory

description: Water oxidation is the key kinetic bottleneck of photoelectrochemical devices for fuel synthesis. Despite advances in the identification of intermediates, elucidating the catalytic mechanism of this multi-redox reaction on metal-oxide photoanodes remains a significant experimental and theoretical challenge. Here we report an experimental analysis of water oxidation kinetics on four widely studied metal oxides, focusing particularly upon hematite. We observe that hematite is able to access a reaction mechanism third order in surface hole density, assigned to equilibration between three surface holes and M(OH)-O-M(OH) sites. This reaction exhibits a remarkably low activation energy (E<sub>a</sub> ~ 60 meV). Density functional theory is employed to determine the energetics of charge accumulation and O-O bond formation on a model hematite 110 surface. The proposed mechanism shows parallels with the function of oxygen evolving complex of photosystem II, and provides new insights to the mechanism of heterogeneous water oxidation on a metal oxide surface.
DOI: 10.5281/zenodo.851634
title: Multihole water oxidation catalysis on hematite photoanodes revealed by operando spectroelectrochemistry and density functional theory

description: Water oxidation is the key kinetic bottleneck of photoelectrochemical devices for fuel synthesis. Despite advances in the identification of intermediates, elucidating the catalytic mechanism of this multi-redox reaction on metal-oxide photoanodes remains a significant experimental and theoretical challenge. Here we report an experimental analysis of water oxidation kinetics on four widely studied metal oxides, focusing particularly upon hematite. We observe that hematite is able to access a reaction mechanism third order in surface hole density, assigned to equilibration between three surface holes and M(OH)-O-M(OH) sites. This reaction exhibits a remarkably low activation energy (E<sub>a</sub> ~ 60 meV). Density functional theory is employed to determine the energetics of charge accumulation and O-O bond formation on a model hematite 110 surface. The proposed mechanism shows parallels with the function of oxygen evolving complex of photosystem II, and provides new insights to the mechanism of heterogeneous water oxidation on a metal oxide surface.
DOI: 10.5281/zenodo.5493698
title: Pre-service and In-service Teachers' Views on Gamification [Dataset & Supplementary Materials]

description: Dataset, survey, and demographic information for <em>Pre-service and In-service Teachers’ Views on Gamification</em>.
DOI: 10.5281/zenodo.5493697
title: Pre-service and In-service Teachers' Views on Gamification [Dataset & Supplementary Materials]

description: Dataset, survey, and demographic information for <em>Pre-service and In-service Teachers’ Views on Gamification</em>.
DOI: 10.6084/m9.figshare.16586105
title: Supplementary Material for: Real-World Evidence for a Smartwatch-Based Parkinson’s Motor Assessment App for Patients Undergoing Therapy Changes

description: <b><i>Introduction:</i></b> Parkinson’s disease (PD) is poorly quantified by patients outside the clinic, and paper diaries have problems with subjective descriptions and bias. Wearable sensor platforms; however, can accurately quantify symptoms such as tremor, dyskinesia, and bradykinesia. Commercially available smartwatches are equipped with accelerometers and gyroscopes that can measure motion for objective evaluation. We sought to evaluate the clinical utility of a prescription smartwatch-based monitoring system for PD utilizing periodic task-based motor assessment. <b><i>Methods:</i></b> Sixteen patients with PD used a smartphone- and smartwatch-based monitoring system to objectively assess motor symptoms for 1 week prior to instituting a doctor recommended change in therapy and for 4 weeks after the change. After 5 weeks the participants returned to the clinic to discuss their results with their doctor, who made therapy recommendations based on the reports and his clinical judgment. Symptom scores were synchronized with the medication diary and the temporal effects of therapy on weekly and hourly timescales were calculated. <b><i>Results:</i></b> Thirteen participants successfully completed the study and averaged 4.9 assessments per day for 3 days per week during the study. The doctor instructed 8 participants to continue their new regimens and 5 to revert to their previous regimens. The smartwatch-based assessments successfully captured intraday fluctuations and short- and long-term responses to therapies, including detecting significant improvements (<i>p</i> &lt; 0.05) in at least one symptom in 7 participants. <b><i>Conclusions:</i></b> The smartwatch-based app successfully captured temporal trends in symptom scores following application of new therapy on hourly, daily, and weekly timescales. These results suggest that validated smartwatch-based PD monitoring can provide clinically relevant information and may reduce the need for traditional office visits for therapy adjustment.
DOI: 10.6084/m9.figshare.16586207
title: Supplementary Material for: Occupational Safety in Chemosensitivity Tests: A Method to Minimize the Risk of Contamination While Maximizing the Safety for the Examiner

description: In vitro chemosensitivity tests are a widely used and established method in research. In laboratory environments, work safety is particularly important when working with carcinogenic, mutagenic, or reprotoxic (CMR) substances. When working with cell cultures, minimizing the risk of contamination with CMR substances and protecting the experimenter must be in the foreground of the experimental setup since risk minimization and occupational safety when handling CMR substances are mandatory. To minimize any personnel risk, studies with solid CMR substances should be carried out in a closed system. However, publications on occupational health and safety in laboratory environments in which CMR substances are tested in cell cultures are rare. Therefore, this article presents an easily applicable and safe method for improving work safety for in vitro chemosensitivity tests when working with CMR substances while also taking cell culture hygiene into account. For this purpose, a risk assessment of the test design was carried out, and the steps that were decisive for safety were highlighted. Some user-friendly and easily reproducible elements are presented, which increase the occupational safety of in vitro chemosensitivity assays, especially by reducing the risk of personnel contamination.
DOI: 10.6084/m9.figshare.16586069
title: Supplementary Material for: Use of Botulinum Toxin for Androgenic Alopecia: A Systematic Review

description: In this systematic review, we summarize the efficacy and safety of intradermal and intramuscular botulinum toxin injections for androgenic alopecia (AGA). Using PubMed, we conducted a literature search up to February 2021 using the following keyword combinations: “botulinum toxin” or “botox” and “androgenetic alopecia,” “hair loss,” or “alopecia.” Five clinical studies met our inclusion criteria: 4 prospective cohorts and 1 randomized clinical trial (RCT). Study durations ranged from 24 to 60 weeks. No studies included control groups or compared botulinum toxin injections against approved treatments. A total of 165 participants were identified – all of whom were males with AGA. Of the 4 studies measuring response rates (i.e., subjects with &gt;0% hair changes), response rates ranged from 75 to 79.1%. Within studies measuring hair count changes from intramuscular injections, changes ranged from 18 to 20.9%. No serious adverse events were reported. Studies on botulinum toxin injections have produced favorable outcomes for AGA subjects. However, results should be interpreted with caution due to the absence of control groups, small numbers of participants, and relatively low Jadad quality scores. Large RCTs are recommended to confirm efficacy and safety, explore the effects of botulinum toxin on females with pattern hair loss, and establish best practices for intradermal and intramuscular injection methodologies.
DOI: 10.6084/m9.figshare.16586069.v1
title: Supplementary Material for: Use of Botulinum Toxin for Androgenic Alopecia: A Systematic Review

description: In this systematic review, we summarize the efficacy and safety of intradermal and intramuscular botulinum toxin injections for androgenic alopecia (AGA). Using PubMed, we conducted a literature search up to February 2021 using the following keyword combinations: “botulinum toxin” or “botox” and “androgenetic alopecia,” “hair loss,” or “alopecia.” Five clinical studies met our inclusion criteria: 4 prospective cohorts and 1 randomized clinical trial (RCT). Study durations ranged from 24 to 60 weeks. No studies included control groups or compared botulinum toxin injections against approved treatments. A total of 165 participants were identified – all of whom were males with AGA. Of the 4 studies measuring response rates (i.e., subjects with &gt;0% hair changes), response rates ranged from 75 to 79.1%. Within studies measuring hair count changes from intramuscular injections, changes ranged from 18 to 20.9%. No serious adverse events were reported. Studies on botulinum toxin injections have produced favorable outcomes for AGA subjects. However, results should be interpreted with caution due to the absence of control groups, small numbers of participants, and relatively low Jadad quality scores. Large RCTs are recommended to confirm efficacy and safety, explore the effects of botulinum toxin on females with pattern hair loss, and establish best practices for intradermal and intramuscular injection methodologies.
DOI: 10.5281/zenodo.5493750
title: dataset related to article "Charcot-Marie-Tooth disease type 2F associated with biallelic HSPB1 mutations"

description: dataset contains Sanger electropherograms of the HSPB1 p.S135F and p.R136L mutations
description: Study supported by grant CP 20/2018 (Care-4NeuroRare) from Fondazione Regionale per la Ricerca Biomedica (FRRB) to F.T.
DOI: 10.5281/zenodo.5493749
title: dataset related to article "Charcot-Marie-Tooth disease type 2F associated with biallelic HSPB1 mutations"

description: dataset contains Sanger electropherograms of the HSPB1 p.S135F and p.R136L mutations
description: Study supported by grant CP 20/2018 (Care-4NeuroRare) from Fondazione Regionale per la Ricerca Biomedica (FRRB) to F.T.
DOI: 10.6084/m9.figshare.16586150
title: Supplementary Material for: Dose-Dependent Association of Inflammatory Cytokines with Carotid Atherosclerosis in Transient Ischaemic Attack: Implications for Clinical Trials

description: <b><i>Introduction:</i></b> The 5-year recurrence risk after ischaemic stroke and transient ischaemic attack (TIA) is 25–30%. Although inflammation may be a target for prevention trials, the contribution of plaque inflammation to acute cerebrovascular events remains unclear. We investigated the association of acute inflammatory cytokines and high-sensitivity C-reactive protein (CRP) with recently symptomatic carotid atherosclerosis in a prospective cohort study. <b><i>Methods:</i></b> Blood and Imaging markers of TIA BIO-TIA) is a multicentre prospective study of imaging and inflammatory markers in patients with TIA. Exclusion criteria were infection and other co-morbid illnesses associated with inflammation. CRP and serum cytokines (interleukin [IL]-6, IL-1β, IL-8, IL-10, IL-12, interferon-γ [IFN-γ] and tumour necrosis factor-α [TNF-α]) were measured. All patients had carotid imaging. <b><i>Results:</i></b> Two hundred and thirty-eight TIA cases and 64 controls (TIA mimics) were included. Forty-nine (20.6%) cases had symptomatic internal carotid artery stenosis. Pro-inflammatory cytokine levels increased in a dose-dependent manner across controls, TIA without carotid stenosis (CS), and TIA with CS (IL-1β, <i>p</i><sub>trend</sub> = 0.03; IL-6, <i>p</i><sub>trend</sub> &lt; 0.0001; IL-8, <i>p</i><sub>trend</sub> = 0.01; interferon (IFN)-γ, <i>p</i><sub>trend</sub> = 0.005; TNF-α, <i>p</i><sub>trend</sub> = 0.003). Results were unchanged when DWI-positive cases were excluded. On multivariable linear regression, only age (<i>p</i> = 0.01) and CS (<i>p</i> = 0.04) independently predicted log-IL-6. On multivariable Cox regression, CRP was the only independent predictor of 90-day stroke recurrence (adjusted hazard ratio per 1-unit increase 1.03 [95% CI: 1.01–1.05], <i>p</i> = 0.003). <b><i>Conclusion:</i></b> Symptomatic carotid atherosclerosis was associated with elevated cytokines in TIA patients after controlling for other sources of inflammation. High-sensitivity CRP was associated with recurrent ischaemic stroke at 90 days. These findings implicate acute plaque inflammation in the pathogenesis of cerebral thromboembolism and support a rationale for randomized trials of anti-inflammatory therapy for stroke patients, who were excluded from coronary trials.
DOI: 10.6084/m9.figshare.16586213
title: finalMI

description: Testing MI data for final stage of BEETL Competitionhttps://github.com/XiaoxiWei/NeurIPS_BEETL
DOI: 10.6084/m9.figshare.16586213.v1
title: finalMI

description: Testing MI data for final stage of BEETL Competitionhttps://github.com/XiaoxiWei/NeurIPS_BEETL
DOI: 10.5281/zenodo.5493640
title: New Insights into the Correlation between Flash Rate and Size in Thunderstorms

description: The uploaded are the figures (involve data) shown in the paper titled "New Insights into the Correlation between Flash Rate and Size in Thunderstorms". This paper is submitting to GRL. The abstract is as follows: The correspondence of the flash rate and size of the thunderstorms between the Tibetan Plateau (TP) and Central and Eastern China (CEC) and Southern Foothills of the Himalayas (SHF) is unlike the previously recommended reverse correspondence between flash rate and size when they are compared between thunderstorms with different dynamic intensity. We find that the size of the effective charge region (ECR) in the TP thunderstorms may be limited to be small by the generally low charge density and small thunderstorm extent resulting from the weakest convection among the three regions, therefore causing the common appearance of lower rate and smaller size of flash. The results suggest that the weak and strong convections both can generate small ECR, and then the small flash size; meanwhile, the reverse correspondence between flash frequency and size may be premised on that the convection intensity of the contrasted thunderstorms both exceed a certain threshold.
DOI: 10.5281/zenodo.5493762
title: Domain Decomposition Method for Helmholtz Equation with Corner Correction

description: This dataset represents numerical simulations of a transmission condition for the Helmholtz equation in the case of a broken line boundary. The results have been achieved using open-source software: GMSH, commit number 418deb961, version 4.6.0, May 7th 2020 (mesh and post-processing), GetDP, version 3.3.0 (finite element solver) and its domain decomposition module GetDDM. The script used to get the dataset is available online (septembre 8th 2021): https://gitlab.onelab.info/doc/models/-/tree/master/DDM-Corner-Helmholtz-2D. The associated paper is currently under review, a preprint can be found on HAL: https://hal.archives-ouvertes.fr/hal-02612368.
DOI: 10.5281/zenodo.5493761
title: Domain Decomposition Method for Helmholtz Equation with Corner Correction

description: This dataset represents numerical simulations of a transmission condition for the Helmholtz equation in the case of a broken line boundary. The results have been achieved using open-source software: GMSH, commit number 418deb961, version 4.6.0, May 7th 2020 (mesh and post-processing), GetDP, version 3.3.0 (finite element solver) and its domain decomposition module GetDDM. The script used to get the dataset is available online (septembre 8th 2021): https://gitlab.onelab.info/doc/models/-/tree/master/DDM-Corner-Helmholtz-2D. The associated paper is currently under review, a preprint can be found on HAL: https://hal.archives-ouvertes.fr/hal-02612368.
DOI: 10.6084/m9.figshare.16586225
title: finalSleep

description: Sleep data for final stage of BEETL Competitionhttps://github.com/XiaoxiWei/NeurIPS_BEETL
DOI: 10.5281/zenodo.5493837
title: Dataset related to article" Missing the pathological expansion in Huntington disease: de novo c.51C&gt;G variant on the expanded allele causing intrafamilial allele dropout"

description: DATASET CONTAINS Sanger sequencing data of the c.51C&gt;G variant in <em>HTT</em> gene.
description: Study supported by grant CP 20/2018 (Care-4NeuroRare) from Fondazione Regionale per la Ricerca Biomedica (FRRB) to F.T, and grant GR-2013-02357821 from the Italian Ministry of Health to Lorenzo Nanetti
DOI: 10.5281/zenodo.5493836
title: Dataset related to article" Missing the pathological expansion in Huntington disease: de novo c.51C&gt;G variant on the expanded allele causing intrafamilial allele dropout"

description: DATASET CONTAINS Sanger sequencing data of the c.51C&gt;G variant in <em>HTT</em> gene.
description: Study supported by grant CP 20/2018 (Care-4NeuroRare) from Fondazione Regionale per la Ricerca Biomedica (FRRB) to F.T, and grant GR-2013-02357821 from the Italian Ministry of Health to Lorenzo Nanetti
DOI: 10.5281/zenodo.5493605
title: dataset related to article: "ATTRV COLLABORATORS. PSYCHOSOCIAL BURDEN AND PROFESSIONAL AND SOCIAL SUPPORT IN PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (ATTRV) AND THEIR RELATIVES IN ITALY"

description: dataset contains information on psychosocial and demographic characteristics of ATTRv patients and relatives
description: STUDY SUPPORTED BY GRANT FROM THE TELETHON FOUNDATION (GRANT NUMBER: GUP15010)
DOI: 10.5281/zenodo.5493604
title: dataset related to article: "ATTRV COLLABORATORS. PSYCHOSOCIAL BURDEN AND PROFESSIONAL AND SOCIAL SUPPORT IN PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (ATTRV) AND THEIR RELATIVES IN ITALY"

description: dataset contains information on psychosocial and demographic characteristics of ATTRv patients and relatives
description: STUDY SUPPORTED BY GRANT FROM THE TELETHON FOUNDATION (GRANT NUMBER: GUP15010)
DOI: 10.5281/zenodo.5483901
title: dataset related to article "Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients"

description: CINZIA CAGNOLI 0000-0001-6863-6687, MICHELA TAIANA 0000-0001-8257-8831, MONICA NIZZARDO 0000-0001-5447-0882, STEFANIA CORTI 0000-0001-5425-969X, VIVIANA PENSATO 0000-0001-9798-2669, ANNA VENERANDO 0000-0002-7489-1833, CINZIA GELLERA 0000-0002-3582-665X, SILVIA FENU 0000-0002-5233-6580, DAVIDE PAREYSON 0000-0001-6854-765X, RICCARDO MASSON 0000-0002-9311-452X, LORENZO MAGGI 0000-0002-0932-5173, ELEONORA DALLA BELLA 0000-0001-6267-9651, GIUSEPPE LAURIA 0000-0001-9773-020X, RENATO MANTEGAZZA 0000-0002-9810-5737, PIA BERNASCONI 0000-0003-0869-2104, ANGELO POLETTI 0000-0002-8883-0468, SILVIA BONANNO 0000-0002-8823-6821, STEFANIA MARCUZZO 0000-0001-6893-6372.
DOI: 10.5281/zenodo.5483900
title: dataset related to article "Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients"

description: CINZIA CAGNOLI 0000-0001-6863-6687, MICHELA TAIANA 0000-0001-8257-8831, MONICA NIZZARDO 0000-0001-5447-0882, STEFANIA CORTI 0000-0001-5425-969X, VIVIANA PENSATO 0000-0001-9798-2669, ANNA VENERANDO 0000-0002-7489-1833, CINZIA GELLERA 0000-0002-3582-665X, SILVIA FENU 0000-0002-5233-6580, DAVIDE PAREYSON 0000-0001-6854-765X, RICCARDO MASSON 0000-0002-9311-452X, LORENZO MAGGI 0000-0002-0932-5173, ELEONORA DALLA BELLA 0000-0001-6267-9651, GIUSEPPE LAURIA 0000-0001-9773-020X, RENATO MANTEGAZZA 0000-0002-9810-5737, PIA BERNASCONI 0000-0003-0869-2104, ANGELO POLETTI 0000-0002-8883-0468, SILVIA BONANNO 0000-0002-8823-6821, STEFANIA MARCUZZO 0000-0001-6893-6372.
DOI: 10.5281/zenodo.5493841
title: Biomarker Signatures of Quality for Engineering Nasal Chondrocyte-Derived Cartilage

description: Data underlying the figures in the publication “Biomarker Signatures of Quality for Engineering Nasal Chondrocyte-Derived Cartilage”, published in <em>Front Bioeng Biotechnol., </em><strong>2020</strong>, 8: 283. (DOI: 10.3389/fbioe.2020.00283). Table of contents: <strong>1. biochem_summary</strong>; Biochemistry data and MBS of pellets made from NC and PC mixtures in the titration experiment. <strong>2. dirty-clean-biochem</strong>; Biochemistry data and MBS of pellets made from passage 2 cells from dirty/clean biopsies. <strong>3. identity_all</strong>; All passage 1 and passage 2 cells of type pure NC and pure PC from the titration and dirty/clean datasets. All PCR data included. <strong>4. identity_titration</strong>; Passage 1 and 2 and pellets made from pure NC and PC populations in the titration experiment. All PCR data included. Average (avg) refers to the average of the biologicsl replicates (which are already the average of the experimental replicates of Data 5). <strong>5. identity_titration_avg</strong>; Passage 1 and 2 and pellets made from pure NC and PC populations in the titration experiment. All PCR data included. All experimental replicate information is included (which are the average of the technical replicates). <strong>6. PCR_cells_summary</strong>; For the purity and potency assays, mixtures of increasing NC to PC cell ratios were created. The PCR data from those mixtures are here for passage 2 and for the pure populations as passage 1. <strong>7. PCR_pellet_summary</strong>; For the purity and potency assays, mixtures of increasing NC to PC cell ratios were created. PCR data from engineered pellets are here included. <strong>8. PCRdirty-clean</strong>; PCR data of cells obtained from dirty/clean biopsies at passage 0,1, and 2. <strong>9. PCRsummary_all</strong>; Combined Data 5, 7, and 8. <strong>10. Proliferation_TOT</strong>; Proliferation rates of cells from clean and dirty biopsies.